Showing results (121-130 of 144) with videos related to
Sort By:
Pageof 15
Pediatric Hematology and Oncology|February 22, 2021
Electrostatic Complementarity of T-Cell Receptor-Alpha CDR3 Domains and Mutant Amino Acids Is Associated with Better Survival Rates for SarcomasMichelle Yeagley, Boris I Chobrutskiy, Etienne C Gozlan, et al.Mammalian Genome : Official Journal of the International Mammalian Genome Society|April 11, 2025
TCR CDR3 chemical complementarity to HPV epitopes is associated with a better outcome for cervical cancerDeo Rei L Agnila, Rahul Jain, Michael J Diaz, et al.Molecular Biotechnology|January 18, 2023
Bacterial Sequencing Reads in Blood Exome Files from Melanoma and Cervical Cancer Patients are Associated with Cancer RecurrenceJessica U Quach, Michael J Diaz, Taha I Huda, et al.Viral Immunology|December 5, 2023
Chemical Complementarity of Tumor Resident, Adaptive Immune Receptor CDR3s and Previously Defined Hepatitis C Virus Epitopes Correlates with Improved Outcomes in Hepatocellular CarcinomaJoanna J Song, Andrea Chobrutskiy, Boris I Chobrutskiy, et al.Journal of Medical Virology|August 25, 2023
TRB CDR3 chemical complementarity with HBV epitopes correlates with increased hepatocellular carcinoma, disease-free survivalJoanna J Song, Andrea Chobrutskiy, Boris I Chobrutskiy, et al.Translational Oncology|March 29, 2021
Chemical complementarity between immune receptors and cancer mutants, independent of antigen presentation protein binding, is associated with increased survival ratesMonica Hsiang, Boris I Chobrutskiy, Michael Diaz, et al.Journal of Cancer Research and Clinical Oncology|July 8, 2023
Blood-based T cell receptor anti-viral CDR3s are associated with worse overall survival for neuroblastomaDorottya B Kacsoh, Michael J Diaz, Etienne C Gozlan, et al.Biochemical Genetics|October 2, 2024
Chemical Complementarity of Blood-Sourced, Breast Cancer-Related TCR CDR3s and the CMV UL29 and IE1 Antigens is Associated with Worse Overall SurvivalPooja Neerumalla, Rahul Jain, Michael T Aboujaoude, et al.Cancer Immunology, Immunotherapy : CII|March 7, 2018
T-cell receptor-β V and J usage, in combination with particular HLA class I and class II alleles, correlates with cancer survival patternsBlake M Callahan, John M Yavorski, Yaping N Tu, et al.Breast Cancer Research and Treatment|March 7, 2023
Adaptive immune receptor features related to breast cancer tissue in Kenyan patients: high immunoglobulin gene expression and high levels of gamma-delta T-cellsKennedy W Mwangi, Moses K Kamita, Jacqueline W Waweru, et al.Pageof 15